Skip to content

Assessing Normal Multichannel Intraluminal Impedance (MII)-pH Parameters for Today's Population

Assessing Normal Multichannel Intraluminal Impedance (MII)-pH Parameters for Today's Population

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01566383
Enrollment
19
Registered
2012-03-29
Start date
2012-03-31
Completion date
2013-08-27
Last updated
2017-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Identify Normal MII-pH Parameters

Brief summary

The normal values of a Multichannel Intraluminal Impedance (MII)-pH study can vary between ages, gender, race and different values of body mass index (BMI). This fact can cause new modifications in the normal values such as making new scales for different age groups or BMI groups. Our aim is to find the normal esophageal MII-pH parameter ranges in volunteers who never experienced reflux related symptoms and are in between the same ranges of age and BMI of our gastroesophageal reflux disease (GERD) patient population.

Interventions

PROCEDURE24-hr pH monitoring

Visit 1 The following will be done: * A medical history including review of your current drugs; * Collection of demographic information; * A manometry, before the 24-hour pH testing, to find the junction between the esophagus and stomach; * 24-hour pH testing will be done Visit 2 You will return to the clinic 24 hours after the visit 1 and the following will occur: * The catheter will be removed from your nose; and * You will return the recording device

Sponsors

Vanderbilt University Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
33 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy male and female adults between the ages of 33-65 * BMI range of 23.9 - 38.9 * Ability to give consent to participate in study

Exclusion criteria

* History of extraesophageal reflux disease symptoms such as chronic or acute cough and/or throat clearing and /or non-cardiac chest pain. * History of gastroesophageal reflux disease (GERD) such as heartburn and/or regurgitation. * History of proton pump inhibitor (PPI) usage ten days prior to the procedure (MII-pH) or H2RA's two days prior to MII-pH and antacids usage on the procedure day. * History of thoracic, gastric or esophageal surgery. * Histories of Diabetes Mellitus, neurological disorders, gastrointestinal disease, taking medication that alter the intragastric acidity or esophageal motility. * Pregnancy or nursing mothers. * Alcohol consumption \>40g/day, smoking \>10cigarettes/day.

Design outcomes

Primary

MeasureTime frameDescription
Identify normal esophageal MII-pH parameter ranges in healthy volunteersFollowing 24-hr pH monitoringOur aim is to find the normal esophageal MII-pH parameter ranges in volunteers who never experienced reflux related symptoms and are in between the same ranges of age and BMI of our GERD patient population.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026